Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect excitement about targeting CD70 in glioblastoma, with words like 'promising' and 'important' highlighting perceived significance. Posts referencing the development of CAR T-cell therapy suggest deep engagement with the therapeutic potential, while mentions of 'microenvironment' and 'immune modulation' reveal interest in mechanistic insights, contributing to overall positive perception and recognition of the research's impact.
The posts generally express positive reactions and acknowledgment of the research's potential.
There is high enthusiasm and curiosity about the therapeutic implications and the new target identified in the study.
Discussions include mentions of the methodology and potential for clinical translation, indicating moderate depth of engagement.
Participants recognize the significance of the findings, but discussions are still emerging, suggesting moderate perceived impact.
New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https://t.co/e7Ofg3IDhW @sheilasinghlab https://t.co/rEjpPHd2MP
RT @jitcancer: New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https:/…
RT @jitcancer: New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https:/…
RT @jitcancer: New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https:/…
The study identifies CD70 as a promising immunotherapeutic target in recurrent glioblastoma, showing that reducing CD70 expression decreases tumor growth and progression. Researchers developed anti-CD70 CAR T-cell…
RT @jitcancer: New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https:/…
RT @jitcancer: New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https:/…
RT @jitcancer: New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https:/…
RT @jitcancer: New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https:/…
New #JITC article: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment https://t.co/e7Ofg3IDhW @sheilasinghlab https://t.co/rEjpPHd2MP